Cargando…
Circ-SFMBT2 drives the malignant phenotypes of esophageal cancer by the miR-107-dependent regulation of SLC1A5
BACKGROUND: Increasing studies focused on the regulatory roles of circular RNAs (circRNAs) in diverse cancers. This study was to evaluate the function and mechanism of circRNA Scm-like with four malignant brain tumor domains 2 (circ-SFMBT2) in esophageal cancer (EC). METHODS: The circ-SFMBT2, microR...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8447765/ https://www.ncbi.nlm.nih.gov/pubmed/34530825 http://dx.doi.org/10.1186/s12935-021-02156-8 |
_version_ | 1784569086720606208 |
---|---|
author | Chang, Zhiwei Fu, Yang Jia, Yongxu Gao, Ming Song, Lijie Zhang, Weijie Zhao, Ruihua Qin, Yanru |
author_facet | Chang, Zhiwei Fu, Yang Jia, Yongxu Gao, Ming Song, Lijie Zhang, Weijie Zhao, Ruihua Qin, Yanru |
author_sort | Chang, Zhiwei |
collection | PubMed |
description | BACKGROUND: Increasing studies focused on the regulatory roles of circular RNAs (circRNAs) in diverse cancers. This study was to evaluate the function and mechanism of circRNA Scm-like with four malignant brain tumor domains 2 (circ-SFMBT2) in esophageal cancer (EC). METHODS: The circ-SFMBT2, microRNA-107 (miR-107) and solute-linked carrier family A1 member 5 (SLC1A5) levels were analyzed by quantitative real-time polymerase chain reaction (qRT-PCR). Cell proliferation was evaluated by 3-(4, 5-dimethylthiazol-2-y1)-2, 5-diphenyl tetrazolium bromide (MTT) assay, colony formation assay and EdU assay. Cell apoptosis and invasion were detected by flow cytometry and transwell assay. Glutamine metabolism was assessed by the corresponding kits for glutamine consumption, α-ketoglutarate production and glutamate production. Western blot was used for protein quantification. The binding analysis was performed using dual-luciferase reporter assay, RNA immunoprecipitation (RIP) and pull-down assays. The functional research of circ-SFMBT2 in vivo was performed by xenograft tumor assay. Exosomes were identified by morphological observation and protein detection. RESULTS: Circ-SFMBT2 was overexpressed in EC samples and cells. Circ-SFMBT2 downregulation inhibited EC cell proliferation, invasion and glutamine metabolism. Circ-SFMBT2 targeted miR-107 and the regulation of circ-SFMBT2 was achieved by sponging miR-107. SLC1A5 was a target of miR-107, and it worked as an oncogene in EC cells. MiR-107 retarded the EC progression by downregulating SLC1A5. Circ-SFMBT2 could affect the SLC1A5 expression by targeting miR-107. Circ-SFMBT2 regulated EC progression in vivo by miR-107/SLC1A5 axis. Circ-SFMBT2 was transferred by exosomes in EC cells. CONCLUSION: These results suggested that circ-SFMBT2 upregulated the SLC1A5 expression to promote the malignant development of EC by serving as a miR-107 sponge. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12935-021-02156-8. |
format | Online Article Text |
id | pubmed-8447765 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-84477652021-09-20 Circ-SFMBT2 drives the malignant phenotypes of esophageal cancer by the miR-107-dependent regulation of SLC1A5 Chang, Zhiwei Fu, Yang Jia, Yongxu Gao, Ming Song, Lijie Zhang, Weijie Zhao, Ruihua Qin, Yanru Cancer Cell Int Primary Research BACKGROUND: Increasing studies focused on the regulatory roles of circular RNAs (circRNAs) in diverse cancers. This study was to evaluate the function and mechanism of circRNA Scm-like with four malignant brain tumor domains 2 (circ-SFMBT2) in esophageal cancer (EC). METHODS: The circ-SFMBT2, microRNA-107 (miR-107) and solute-linked carrier family A1 member 5 (SLC1A5) levels were analyzed by quantitative real-time polymerase chain reaction (qRT-PCR). Cell proliferation was evaluated by 3-(4, 5-dimethylthiazol-2-y1)-2, 5-diphenyl tetrazolium bromide (MTT) assay, colony formation assay and EdU assay. Cell apoptosis and invasion were detected by flow cytometry and transwell assay. Glutamine metabolism was assessed by the corresponding kits for glutamine consumption, α-ketoglutarate production and glutamate production. Western blot was used for protein quantification. The binding analysis was performed using dual-luciferase reporter assay, RNA immunoprecipitation (RIP) and pull-down assays. The functional research of circ-SFMBT2 in vivo was performed by xenograft tumor assay. Exosomes were identified by morphological observation and protein detection. RESULTS: Circ-SFMBT2 was overexpressed in EC samples and cells. Circ-SFMBT2 downregulation inhibited EC cell proliferation, invasion and glutamine metabolism. Circ-SFMBT2 targeted miR-107 and the regulation of circ-SFMBT2 was achieved by sponging miR-107. SLC1A5 was a target of miR-107, and it worked as an oncogene in EC cells. MiR-107 retarded the EC progression by downregulating SLC1A5. Circ-SFMBT2 could affect the SLC1A5 expression by targeting miR-107. Circ-SFMBT2 regulated EC progression in vivo by miR-107/SLC1A5 axis. Circ-SFMBT2 was transferred by exosomes in EC cells. CONCLUSION: These results suggested that circ-SFMBT2 upregulated the SLC1A5 expression to promote the malignant development of EC by serving as a miR-107 sponge. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12935-021-02156-8. BioMed Central 2021-09-16 /pmc/articles/PMC8447765/ /pubmed/34530825 http://dx.doi.org/10.1186/s12935-021-02156-8 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Primary Research Chang, Zhiwei Fu, Yang Jia, Yongxu Gao, Ming Song, Lijie Zhang, Weijie Zhao, Ruihua Qin, Yanru Circ-SFMBT2 drives the malignant phenotypes of esophageal cancer by the miR-107-dependent regulation of SLC1A5 |
title | Circ-SFMBT2 drives the malignant phenotypes of esophageal cancer by the miR-107-dependent regulation of SLC1A5 |
title_full | Circ-SFMBT2 drives the malignant phenotypes of esophageal cancer by the miR-107-dependent regulation of SLC1A5 |
title_fullStr | Circ-SFMBT2 drives the malignant phenotypes of esophageal cancer by the miR-107-dependent regulation of SLC1A5 |
title_full_unstemmed | Circ-SFMBT2 drives the malignant phenotypes of esophageal cancer by the miR-107-dependent regulation of SLC1A5 |
title_short | Circ-SFMBT2 drives the malignant phenotypes of esophageal cancer by the miR-107-dependent regulation of SLC1A5 |
title_sort | circ-sfmbt2 drives the malignant phenotypes of esophageal cancer by the mir-107-dependent regulation of slc1a5 |
topic | Primary Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8447765/ https://www.ncbi.nlm.nih.gov/pubmed/34530825 http://dx.doi.org/10.1186/s12935-021-02156-8 |
work_keys_str_mv | AT changzhiwei circsfmbt2drivesthemalignantphenotypesofesophagealcancerbythemir107dependentregulationofslc1a5 AT fuyang circsfmbt2drivesthemalignantphenotypesofesophagealcancerbythemir107dependentregulationofslc1a5 AT jiayongxu circsfmbt2drivesthemalignantphenotypesofesophagealcancerbythemir107dependentregulationofslc1a5 AT gaoming circsfmbt2drivesthemalignantphenotypesofesophagealcancerbythemir107dependentregulationofslc1a5 AT songlijie circsfmbt2drivesthemalignantphenotypesofesophagealcancerbythemir107dependentregulationofslc1a5 AT zhangweijie circsfmbt2drivesthemalignantphenotypesofesophagealcancerbythemir107dependentregulationofslc1a5 AT zhaoruihua circsfmbt2drivesthemalignantphenotypesofesophagealcancerbythemir107dependentregulationofslc1a5 AT qinyanru circsfmbt2drivesthemalignantphenotypesofesophagealcancerbythemir107dependentregulationofslc1a5 |